期刊文献+

Wnt/β-catenin信号通路和神经系统疾病关系研究进展 被引量:4

Research progress on the relationship between Wnt/β-catenin signaling pathway and neurological disorders
原文传递
导出
摘要 近年来大量临床及基础研究报道,Wnt/p-catenin信号通路与多种神经系统疾病的发生发展有着密切关系。为提高人们对Wnt/p-catenin信号通路与神经系统疾病关系的重视,并为治疗提供新的靶点,本文就Wnt/p-catenin信号通路与阿尔茨海默病、帕金森病、癫痫、多发性硬化症以及重症肌无力关系的研究进展作一综述。 Abundant clinical and basic studies in recent years reported the high association of Wnt/β-catenin signaling pathway with the incidence and development of multiple neurological disorders.In order to improve the attention about the relationship between Wnt/β-catenin signaling pathway and neurological disorders,and to provide new therapy target,this article reviews the research progress on the relationship between wnt/β-catenin signaling pathway and Parkinson′s disease,Alzheimer′s disease,epilepsy,multiple sclerosis and myasthenia gravis.
作者 洪康杰 章正祥 李净娅 蒋旭宏 裘昌林 侯群 裘辉 Hong Kangjie;Zhang Zhengxiang;Li Jingya;Jiang Xuhong;Qiu Changlin;Hou Qun;Qiu Hui(the First Clinical College of Zhejiang Chinese Medical University,Hangzhou 310053,China;Department of Neurology,the First Affiliated Hospital of Zhejiang Chinese Medical University,Hangzhou 310006,China;Department of Traditional Chinese Medicine,the Third Affiliated Hospital of Zhejiang Chinese Medical University,Hangzhou 310005,China)
出处 《中国医师杂志》 CAS 2020年第5期789-793,共5页 Journal of Chinese Physician
基金 2017年度浙江省中医药科学研究基金项目(2017ZA047) 浙江省中医药科技计划项目(2014ZA048,2019ZA064) 2012年全国名老中医药专家传承工作室建设项目(国中医药人教函〔2012〕149号) 国家中医药管理局全国名老中医药专家传承工作室建设项目(国中医药人教发〔2016〕42号)。
关键词 WNT信号通路 WNT蛋白质类 [3连环素冲枢神经系统疾病 综述 Wnt signaling pathway Wnt proteins Beta catenin Central nervous system diseases Review
  • 相关文献

参考文献3

二级参考文献35

  • 1彭丹涛,许贤豪,佘子瑜.新斯的明试验改良结果判定法研究[J].中国神经免疫学和神经病学杂志,2007,14(1):1-3. 被引量:26
  • 2Conti-Fine BM, Milani M, Kaminski HJ. Myasthenia gravis: past, present, and tuture[J]. J Clin Invest, 2006, 116(11): 2843-2854.
  • 3Kerry E, Elsais A, Argov Z, et al. NE. EFNS/ENS Guidelines for the treatment of ocular myasthenia [ J ]. Eur J Neurol, 2014, 21(5) : 687-693.
  • 4Luehanok U, Kaminski HJ. Ocular myasthenia: diagnostic and treatment recommendations and the evidence basel[ J ]. Curr Opin Neurol, 2008, 21 ( 1 ) : 8-15.
  • 5Jani-Acsadi A, Lisak RP. Myasthenic crisis: guidelines for prevention and treatment[ J]. J Neurol Sci, 2007, 261 (1-2) : 127-133.
  • 6Meriggioli MN, Sanders DB. Autoimmune myasthcnia gravis: emerging clinical and biological heterogeneity[ J]. Lancet Neurol, 2009, 8(5) : 475-490.
  • 7Meyer DM, Herbert MA, Sobhani NC, et al. Comparative clinical outcomes of thymectomy for myasthenia gravis performed by extended transsternal and minimally invasive approaches[ J]. Ann Thorac Surg, 2009, 87(2) : 385-390.
  • 8Skeie GO, Apostolski S, Evoli A, et al. Guidelines for treatment of autoimmune neuromuscular transmission disorders [ J ]. Eur J Neurol, 2010, 17(7) : 893-902.
  • 9Jani-Acsadi A, Lisak RP. Myasthenia gravis [ J ]. Curr Treat Options Neurol, 2010, 12 ( 3 ) : 231-243.
  • 10Kosmidis ML, Dalakas MC. Practical considerations on the use of rituximab in autoimmune neurological disorders [ J ].Ther Adv Neurol Disord, 2010, 3(2): 93-105.

共引文献284

同被引文献31

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部